Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia (Q30983667)

28 June 2017

title

Fluvastatin therapy improves microcirculation in patients with hyperlipidaemia (English)

1 reference

28 June 2017

1 reference

Haak E

1

1 reference

28 June 2017

Abletshauser C

2

1 reference

28 June 2017

Weber S

3

1 reference

28 June 2017

Goedicke C

4

1 reference

28 June 2017

Martin N

5

1 reference

28 June 2017

Hermanns N

6

1 reference

28 June 2017

Lackner K

7

1 reference

28 June 2017

Kusterer K

8

1 reference

28 June 2017

Usadel KH

9

1 reference

28 June 2017

Haak T

10

1 reference

28 June 2017

publication date

1 April 2001

1 reference

28 June 2017

1 reference

28 June 2017

volume

155

1 reference

28 June 2017

issue

2

1 reference

28 June 2017

page(s)

395-401

1 reference

Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Is endothelial dysfunction reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Regulatory functions of the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Role of nitric oxide in reactive hyperemia of the guinea pig heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Fluvastatin in severe hypercholesterolemia:Analysis of a clinical trial database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Fluvastatin: a review of its use in lipid disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Vasodilatory Capacity of Forearm Resistance Vessels Is Augmented in Hypercholesterolemic Patients After Treatment with Fluvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Endothelial dysfunction in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Endothelial modulation of vascular tone: relevance to coronary angioplasty and restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Cutaneous blood flow abnormalities in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Effects of tobacco smoke inhalation on capillary blood flow in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Method of video capillary microscopy: determination of geometric and dynamic measuring parameters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Microvascular skin blood flow following the ingestion of 75 g glucose in healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Measurement error and correlation coefficients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

The importance of erythrocyte deformability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0021-9150(00)00567-0

10.1016/S0021-9150(00)00567-0

7 January 2021

Identifiers

DOI

1 reference

28 June 2017

1 reference